Santen Inc.
NAPA, CA- March 31, 2011 -Santen Inc., a wholly-owned subsidiary of Santen Pharmaceutical Co., Ltd., Osaka, Japan, has announced that its U.S. corporate headquarters, currently located in Napa, California, will relocate to 2100 Powell in Emeryville, California in early July 2011.
"In the preparation of our new strategic plan we can see that there will be substantial expansion of the organization and we could not have accommodated this growth in the existing facility in Napa," stated Akihiro Tsujimura, Chief Operating Officer (COO) of Santen Inc. "Since we will experience a significant demand for new staff we believe that the new location will make it easier to recruit the highest quality talent as we will have increased access to the greater San Francisco Bay Area bio-pharmaceutical talent pool."
In addition, it was noted that the increased interaction between the Company's Japanese and European colleagues was a secondary driving force behind the relocation, seeking a more convenient location for international transportation.
The new location in Emeryville was chosen for a number of reasons, including:
- Access to a strong bio-pharmaceutical talent pool
- A location that would provide the greatest opportunity to retain the company’s existing experienced ophthalmic talent
- Improved access to international transportation
Santen will occupy nearly 50,000 square feet on the top two floors of the 16-story 2100 Powell building, which has significantly more square footage than Santen’s current Napa facility and is projected to accommodate the growth in the organization over the next five years.
"Emeryville provides an excellent centralized location that provides easy access to both Oakland and San Francisco airports which will facilitate increased collaboration between our corporate and regional R&D organizations. Collaboration among our regional R&D organizations is a cornerstone of our strategy to accelerate our clinical development timelines," said Toshiaki Nishihata PhD, President and CEO of Santen Inc. "From this site we also have easy access to UC San Francisco, UC Berkeley and Stanford, rich sources of intellectual capital and support for our R&D initiatives."
About Emeryville, California
Emeryville is a small city located in Alameda County, California. It is located in a corridor between the cities of Berkeley and Oakland, extending to the shore of San Francisco Bay. In 2009, the population of Emeryville was 10,087.
Its proximity to San Francisco, the Bay Bridge, the University of California, Berkeley, and Silicon Valley has been a catalyst for recent economic growth. It is home to a number of other pharmaceutical companies such as Novartis, aaiPharma, Adama Pharmaceuticals, Bayer, NovaBay Pharmaceuticals, Peplin, and Tethye Bioscience.
For more information on Emeryville, California visit http://www.ci.emeryville.ca.us/ or http://en.wikipedia.org/wiki/Emeryville,_California.
About 2100 Powell
2100 Powell is located along Emeryville's waterfront and is centrally located at the intersection of Interstate Highways 80, 880, 580 and the Bay Bridge. The building is owned and managed by Hines, and is LEED® Gold certified (the Gold certification is under the U.S Green Building Council's Leadership in Energy and Environmental Design rating system for Existing Buildings (LEED-EB).
About Santen Inc.
Santen Inc., based in Napa, California, is the U.S. subsidiary of Santen Pharmaceutical Co., Ltd., a billion-dollar global company headquartered in Osaka, Japan since 1890. Santen researches, develops and markets ophthalmic products for physicians worldwide. Santen has subsidiaries in the U.S., Europe and Asia, including its wholly-owned Napa, California-based Santen Inc. Santen Inc. also maintains a satellite business development office in Irvine, California which provides direct access to the regional cluster of ophthalmic companies operating in that area. Among prescription ophthalmic pharmaceuticals, Santen holds the top share within the Japanese and Chinese markets and is one of the leading ophthalmic companies worldwide. Santen’s global product pipeline includes a number of prescription pharmaceuticals in varying clinical trial phases. A detailed listing of products, as well as additional corporate information, is available online at www.santeninc.com.